Is there a role for adjuvant treatment in patients with T3N0M0 breast cancer treated by modified radical mastectomy?

被引：0
|
作者：
Hayes, MK
Ravi, A
Antonacci, R
Schiff, PB
机构：
来源：
RADIOLOGY | 1997年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：337 / 337
页数：1
相关论文
共 50 条
  • [41] Is There Any Role of Adjuvant Chemotherapy for T3N0M0 or T1N2M0 Gastric Cancer Patients in Stage II in the 7th TNM but Stage I in the 6th TNM System?
    Lee, Kyung-Goo
    Lee, Hyuk-Joon
    Oh, Seung-Young
    Yang, Jun-Young
    Ahn, Hye-Seong
    Suh, Yun-Suhk
    Kong, Seong-Ho
    Kim, Tae-Yong
    Oh, Do-Youn
    Im, Seock-Ah
    Lee, Kuhn Uk
    Kim, Woo Ho
    Bang, Yung-Jue
    Yang, Han-Kwang
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (04) : 1234 - 1243
  • [42] Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer
    Meric, F
    Mirza, NQ
    Buzdar, AU
    Hunt, KK
    Ames, FC
    Ross, MI
    Pollock, RE
    Newman, LA
    Feig, BW
    Strom, EA
    Buchholz, TA
    McNeese, MD
    Hortobagyi, GN
    Singletary, SE
    ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (06) : 435 - 440
  • [43] Prognostic Implications of Pathological Lymph Node Status After Preoperative Chemotherapy for Operable T3N0M0 Breast Cancer
    Funda Meric
    Nadeem Q. Mirza
    Aman U. Buzdar
    Kelly K. Hunt
    Fred C. Ames
    Merrick I. Ross
    Raphael E. Pollock
    Lisa A. Newman
    Barry W. Feig
    Eric A. Strom
    Thomas A. Buchholz
    Marsha D. McNeese
    Gabriel N. Hortobagyi
    S. Eva Singletary
    Annals of Surgical Oncology, 2000, 7 : 435 - 440
  • [44] Recurrence risk evaluation in T1N1M0/T2N0M0/T3N0M0 gastric cancer with TP53 codon 72 polymorphisms
    Ohmori, Yukimi
    Nomura, Takashi
    Fukushima, Norimasa
    Takahashi, Fumiaki
    Iwaya, Takeshi
    Koeda, Keisuke
    Nishizuka, Satoshi S.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (07) : 1154 - 1161
  • [45] Outcomes of Mastectomy With and Without Adjuvant Radiation for T1-2N0M0 Triple Negative Breast Cancer: SEER Analysis
    Szeja, S.
    Hatch, S. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E30 - E31
  • [46] Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx Reply
    Witek, Matthew E.
    Hartig, Gregory K.
    Harari, Paul M.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2018, 144 (06) : 543 - 543
  • [47] Impact of chemotherapy on prognosis of resectable pathological T3N0M0 esophageal cancer patients: a population-based study
    Gu, Xiang
    Ge, Yizhi
    Liu, Jia
    Ding, Qian
    Chu, Junfeng
    Tian, Guangyu
    Chen, Xiaojun
    FUTURE ONCOLOGY, 2021, 17 (30) : 3925 - 3940
  • [48] T3N0M0 NSCLC Subtypes - A Signal for Disparate Outcomes after Surgery
    Ferrari-Light, Dana
    Kneuertz, Peter J.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2023, 35 (04) : 805 - 806
  • [49] IMPACT OF ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH T1N1M0/T2N0M0 GASTRIC CANCER
    Chen, Yi Fu
    Le, Puo-Hsien
    Chen, Tsung Hsing
    Kuo, Chia Jung
    Wang, Shang Yu
    Chou, Wen Chi
    Yeh, Ta Sen
    Hsu, Jun Te
    GASTROENTEROLOGY, 2024, 166 (05) : S669 - S669
  • [50] Post-mastectomy radiotherapy in pT3N0M0 breast cancer:: is it needed?
    Helintö, M
    Blomqvist, C
    Heikkilä, P
    Joensuu, H
    RADIOTHERAPY AND ONCOLOGY, 1999, 52 (03) : 213 - 217
12345